Trial Profile

A Phase 3 clinical trial of etoposide toniribate in patients with refractory biliary tract cancer

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 01 Mar 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etoposide-toniribate (Primary)
Indications Biliary cancer
Focus Therapeutic Use

Most Recent Events

01 Mar 2019 Imbrium Therapeutics term is not available hence not added, kindly add once the term is available. Route and form assumed.
01 Mar 2019 New trial record
22 Feb 2019 According to an Imbrium Therapeutics media release, the company expects to initiate a Phase 3 clinical trial in 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com